Furthermore, TPL inhibited the activation of the NF-κB signaling pathway, directly suppressing the expression of VEGF in HUVECs, breast cancer cells MDAMB-231 and MCF-7, thereby affecting tumor cell angiogenesis [40–42]. Here, VEGFA is linked to neoplasm.